Karen Pendergrass

Karen Pendergrass, Standards Team

About

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.

Recent Posts

2025-07-22

How Toxic and Essential Metals Disrupt Gut Microbiota: A Comprehensive Review

This review maps the bidirectional interactions between toxic and essential metals and the gut microbiota, detailing microbial shifts and host impacts. It highlights specific microbial taxa disrupted by metals like arsenic, cadmium, and nickel, providing insight into metal-driven dysbiosis and its implications for disease pathogenesis.

2025-07-22

Does Physical Exercise Lower Endometriosis Risk? Systematic Review Insights

This systematic review found insufficient evidence to confirm that physical exercise reduces endometriosis risk or symptoms, though some data suggest a potential protective effect. Well-designed controlled trials are needed to clarify the role of exercise in endometriosis prevention and management.

2025-07-17

Guar Gum

Guar gum is a water-soluble and gel-forming x,x soluble fiber derived from the guar bean (Cyamopsis tetragonoloba), an annual legume crop that is primarily cultivated in India and Pakistan, along with small quantities in the United States, Australia, and Africa. Guar gum is commonly found in foods and dietary supplements. Guar gum has several potential health benefits: […]

2025-07-09

Staphylococcus aureus (S. Aureus)

Staphylococcus aureus is a versatile skin and mucosal commensal that can transition into a highly virulent pathobiont. Known for its immune-evasive strategies, toxin production, and antibiotic resistance, it plays a significant role in chronic infections and microbiome imbalance.

2025-07-07

Ureaplasma urealyticum (U. urealyticum)

Ureaplasma urealyticum is a wall-less, urease-producing pathobiont of the urogenital tract linked to infertility, preterm birth, and neonatal lung disease. Its virulence stems from nickel-dependent urease activity, immune-evasive antigens, and proinflammatory lipoproteins.

2025-07-07

Streptococcus spp.

Streptococcus is a genus of gram-positive, facultatively anaerobic bacteria commonly found in pairs or chains. Important human pathogens include Streptococcus pneumoniae, Streptococcus pyogenes (group A strep), and Streptococcus agalactiae (group B strep).

2025-07-07

Streptococcus agalactiae (GBS)

Streptococcus agalactiae, also known as Group B Streptococcus (GBS), is a Gram-positive, facultative anaerobe commonly found as a commensal organism in the gastrointestinal and urogenital tracts of humans. While asymptomatic colonization is frequent, GBS is also a major pathogen, particularly in neonates, pregnant women, and immunocompromised individuals.

2025-07-07

H pylori

Helicobacter pylori, a bacterium that colonizes the human stomach, is primarily known for its pathogenic role, particularly in causing peptic ulcers, chronic gastritis, and its association with gastric cancer. However, research has also suggested that H. pylori infection may have protective roles against other diseases. The concept of H. pylori exerting protective effects against certain […]